Prostaglandins and estradiol-induced attenuation of hypoxic pulmonary vasoconstriction

J. T. Sylvester, J. B. Gordon, R. L. Malamet, R. C. Wetzel

Research output: Contribution to journalArticle

Abstract

Pretreatment with estradiol (20 mg IM) attenuated vasoreactivity to decreases in inspired PIO2 lowered baseline resistance measured under conditions of maximal vasodilation (PIO2 = 0 mm Hg), and appeared to increase prostaglandin release in isolated, blood-perfused lungs of juvenile female sheep. Indomethacin (40 μg/ml) inhibited prostaglandin release and restored hypoxic vasoreactivity in estrogen-treated lungs, but did not alter the estrogen-induced decrease in baseline resistance. These results suggest that estradiol enhanced the production of prostaglandins which secondarily attenuated hypoxic vasoreactivity. The estradiol-induced decrease in baseline resistance, however, must have been mediated by some other mechanism.

Original languageEnglish (US)
JournalChest
Volume88
Issue number4 SUPPL.
StatePublished - 1985

Fingerprint

Vasoconstriction
Prostaglandins
Estradiol
Lung
Estrogens
Vasodilation
Indomethacin
Sheep

ASJC Scopus subject areas

  • Pulmonary and Respiratory Medicine

Cite this

Sylvester, J. T., Gordon, J. B., Malamet, R. L., & Wetzel, R. C. (1985). Prostaglandins and estradiol-induced attenuation of hypoxic pulmonary vasoconstriction. Chest, 88(4 SUPPL.).

Prostaglandins and estradiol-induced attenuation of hypoxic pulmonary vasoconstriction. / Sylvester, J. T.; Gordon, J. B.; Malamet, R. L.; Wetzel, R. C.

In: Chest, Vol. 88, No. 4 SUPPL., 1985.

Research output: Contribution to journalArticle

Sylvester, JT, Gordon, JB, Malamet, RL & Wetzel, RC 1985, 'Prostaglandins and estradiol-induced attenuation of hypoxic pulmonary vasoconstriction', Chest, vol. 88, no. 4 SUPPL..
Sylvester JT, Gordon JB, Malamet RL, Wetzel RC. Prostaglandins and estradiol-induced attenuation of hypoxic pulmonary vasoconstriction. Chest. 1985;88(4 SUPPL.).
Sylvester, J. T. ; Gordon, J. B. ; Malamet, R. L. ; Wetzel, R. C. / Prostaglandins and estradiol-induced attenuation of hypoxic pulmonary vasoconstriction. In: Chest. 1985 ; Vol. 88, No. 4 SUPPL.
@article{5444573449794ea4aea5c4402b4810ef,
title = "Prostaglandins and estradiol-induced attenuation of hypoxic pulmonary vasoconstriction",
abstract = "Pretreatment with estradiol (20 mg IM) attenuated vasoreactivity to decreases in inspired PIO2 lowered baseline resistance measured under conditions of maximal vasodilation (PIO2 = 0 mm Hg), and appeared to increase prostaglandin release in isolated, blood-perfused lungs of juvenile female sheep. Indomethacin (40 μg/ml) inhibited prostaglandin release and restored hypoxic vasoreactivity in estrogen-treated lungs, but did not alter the estrogen-induced decrease in baseline resistance. These results suggest that estradiol enhanced the production of prostaglandins which secondarily attenuated hypoxic vasoreactivity. The estradiol-induced decrease in baseline resistance, however, must have been mediated by some other mechanism.",
author = "Sylvester, {J. T.} and Gordon, {J. B.} and Malamet, {R. L.} and Wetzel, {R. C.}",
year = "1985",
language = "English (US)",
volume = "88",
journal = "Chest",
issn = "0012-3692",
publisher = "American College of Chest Physicians",
number = "4 SUPPL.",

}

TY - JOUR

T1 - Prostaglandins and estradiol-induced attenuation of hypoxic pulmonary vasoconstriction

AU - Sylvester, J. T.

AU - Gordon, J. B.

AU - Malamet, R. L.

AU - Wetzel, R. C.

PY - 1985

Y1 - 1985

N2 - Pretreatment with estradiol (20 mg IM) attenuated vasoreactivity to decreases in inspired PIO2 lowered baseline resistance measured under conditions of maximal vasodilation (PIO2 = 0 mm Hg), and appeared to increase prostaglandin release in isolated, blood-perfused lungs of juvenile female sheep. Indomethacin (40 μg/ml) inhibited prostaglandin release and restored hypoxic vasoreactivity in estrogen-treated lungs, but did not alter the estrogen-induced decrease in baseline resistance. These results suggest that estradiol enhanced the production of prostaglandins which secondarily attenuated hypoxic vasoreactivity. The estradiol-induced decrease in baseline resistance, however, must have been mediated by some other mechanism.

AB - Pretreatment with estradiol (20 mg IM) attenuated vasoreactivity to decreases in inspired PIO2 lowered baseline resistance measured under conditions of maximal vasodilation (PIO2 = 0 mm Hg), and appeared to increase prostaglandin release in isolated, blood-perfused lungs of juvenile female sheep. Indomethacin (40 μg/ml) inhibited prostaglandin release and restored hypoxic vasoreactivity in estrogen-treated lungs, but did not alter the estrogen-induced decrease in baseline resistance. These results suggest that estradiol enhanced the production of prostaglandins which secondarily attenuated hypoxic vasoreactivity. The estradiol-induced decrease in baseline resistance, however, must have been mediated by some other mechanism.

UR - http://www.scopus.com/inward/record.url?scp=0022239421&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0022239421&partnerID=8YFLogxK

M3 - Article

C2 - 3840073

AN - SCOPUS:0022239421

VL - 88

JO - Chest

JF - Chest

SN - 0012-3692

IS - 4 SUPPL.

ER -